More On

FDA proposes charging compounding pharmacies fees to fund extra oversight in wake of meningitis outbreak

The agency feels it doesn’t have enough authority over specialty pharmacies

Compounding pharmacies across the country are likely having flashbacks to mean high school teachers who would give the whole class extra homework to punish one student’s misconduct. Except now the teacher is the Food and Drug Administration (FDA), and the homework is extra fees.

The pharmacies have last year’s deadly meningitis outbreak to thank for this predicament. The outbreak was linked to a compounding pharmacy in Massachusetts with a history of poor contamination control. In an official blog post on Friday, FDA Commissioner Margaret Hamburg proposed charging compounding pharmacies fees to help pay for the additional oversight needed to prevent such an outbreak from happening again.

Join the Conversation

Advertisement. Closing in 15 seconds.